Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin dumping

This article was originally published in The Tan Sheet

Executive Summary

U.S. Customs service will impose antidumping duties on bulk aspirin imports from China following a June 22 ITC determination the imports threaten U.S. industry with material injury. In an amended final determination June 21, the ITA revises previously announced weighted-average dumping margins for two Chinese firms: Shandong Xinhua Pharmaceutical Factory, 16.5% (previously 42.8%) and Jilin Pharmaceutical, 10.9% (previously 4.7%). The PRC-wide rate of 144% is unchanged (1"The Tan Sheet" May 29, In Brief)

You may also be interested in...



Chinese bulk aspirin

Shandong Xinhua Pharmaceutical did not make bulk aspirin sales "below normal value" from July 1, 2002 through June 30, 2003, the International Trade Administration says April 8. ITA therefore preliminarily finds that an antidumping order for the Chinese firm should be revoked, and invites comment before publication of final notice. The Department of Commerce originally published an antidumping order on Shandong Xinhua bulk aspirin in July 2000 (1"The Tan Sheet" July 3, 2000, p. 2)...

Chinese bulk aspirin

Shandong Xinhua Pharmaceutical did not make bulk aspirin sales "below normal value" from July 1, 2002 through June 30, 2003, the International Trade Administration says April 8. ITA therefore preliminarily finds that an antidumping order for the Chinese firm should be revoked, and invites comment before publication of final notice. The Department of Commerce originally published an antidumping order on Shandong Xinhua bulk aspirin in July 2000 (1"The Tan Sheet" July 3, 2000, p. 2)...

Chinese bulk aspirin

Shandong Xinhua Pharmaceutical did not make bulk aspirin sales "below normal value" from July 1, 2002 through June 30, 2003, the International Trade Administration says April 8. ITA therefore preliminarily finds that an antidumping order for the Chinese firm should be revoked, and invites comment before publication of final notice. The Department of Commerce originally published an antidumping order on Shandong Xinhua bulk aspirin in July 2000 (1"The Tan Sheet" July 3, 2000, p. 2)...

Related Content

Topics

UsernamePublicRestriction

Register

PS091368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel